AAAAAA
Results: 1-25/32
Authors:
CELIK I
KARS A
GULER N
BARISTA I
TEKUZMAN G
OZYILKAN O
HAYRAN M
FIRAT D
Citation: I. Celik et al., PHASE-II TRIAL OF MINE AS A FRONT-LINE THERAPEUTIC MODALITY IN INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS, European journal of cancer, 34(5), 1998, pp. 759-760
Authors:
CAY F
ONAT H
SAIP P
KARS A
DEMIRKAZIK A
AKBULUT H
KOCA S
AKYOL F
AKTAN G
FIRAT D
Citation: F. Cay et al., CISPLATIN AND EPIRUBICIN INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY IN LIMITED STAGE SMALL-CELL LUNG-CANCER (LS-SCLC), Annals of oncology, 9, 1998, pp. 502-502
Authors:
DEMIRKAZIK A
ONAT H
SAIP P
OZGUROGLU M
KARS A
CAY F
DEMIR G
UNER A
ARPACI F
AKTAN G
Citation: A. Demirkazik et al., HIGH-DOSE EPIRUBICIN AND CISPLATIN INDUCTION CHEMOTHERAPY SEQUENTIALLY FOLLOWED BY IFOSFAMIDE AND ETOPOSIDE CHEMOTHERAPY IN EXTENSIVE-STAGESMALL-CELL LUNG-CANCER (ES-SCLC), Annals of oncology, 9, 1998, pp. 505-505
Authors:
YALCIN S
KARS A
OZISIK Y
TEKUZMAN G
OZYILKAN O
CELIK I
BARISTA I
GULLU I
GULER N
BALTALI E
FIRAT D
Citation: S. Yalcin et al., VB-CHEP CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS, European journal of haematology, 61(4), 1998, pp. 261-265
Authors:
KOC Y
AKPEK G
KANSU E
KARS A
TEKUZMAN G
BALTALI E
GULER N
BARISTA I
GULLU I
OZISIK Y
FIRAT D
Citation: Y. Koc et al., BOLUS AND CONTINUOUS-INFUSION MITOXANTRONE IN NEWLY-DIAGNOSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF 2 CONSECUTIVE PHASE-II CLINICAL-STUDIES, Cancer investigation, 16(6), 1998, pp. 355-365
Authors:
YALCIN S
GULLU I
BARISTA J
TEKUZMAN G
OZISIK Y
CELIK I
KARS A
Citation: S. Yalcin et al., TREATMENT OF ADVANCED REFRACTORY SARCOMAS WITH IFOSFAMIDE AND ETOPOSIDE COMBINATION CHEMOTHERAPY, Cancer investigation, 16(5), 1998, pp. 297-302
Authors:
CELIK I
ERMAN M
KARS A
TEKUZMAN G
Citation: I. Celik et al., THE EFFICACY OF CCNU IN NONSMALL CELL LUNG-CARCINOMA PRESENTING WITH CRANIAL METASTASES, Journal of experimental & clinical cancer research, 17(3), 1998, pp. 375-375
Authors:
ZENGIN N
KARS A
OZISIK Y
CANPINAR H
TURKER A
RUACAN S
Citation: N. Zengin et al., ALEUKEMIC LEUKEMIA-CUTIS IN A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of the American Academy of Dermatology, 38(4), 1998, pp. 620-621
Authors:
KOSTAKOGLU L
GUC D
CANPINAR H
KARS A
ALPER E
KIRATLI P
HAYRAN M
GUNDUZ U
KANSU E
Citation: L. Kostakoglu et al., P-GLYCOPROTEIN EXPRESSION BY TECHNETIUM-99M-MIBI SCINTIGRAPHY IN HEMATOLOGIC MALIGNANCY, The Journal of nuclear medicine, 39(7), 1998, pp. 1191-1197
Authors:
CELIK I
APRAS S
KARS A
BARISTA I
GULLU I
GULER N
KANSU E
Citation: I. Celik et al., PERSISTENT HYPERCALCEMIA LEADING TO ACUTE-PANCREATITIS IN A PATIENT WITH RELAPSED MYELOMA AND RENAL-FAILURE, Nephron, 79(1), 1998, pp. 109-110
Authors:
KARS A
CELIK I
KANSU E
TEKUZMAN G
OZISIK Y
GULER N
BARISTA I
GULLU I
YALCIN S
ALTUNDAG K
ZENGIN N
TURKER A
HAYRAN M
BALTALT E
FIRAT D
Citation: A. Kars et al., MAINTENANCE THERAPY WITH ALPHA-INTERFERON FOLLOWING FIRST-LINE VAD INMULTIPLE-MYELOMA, European journal of haematology, 59(2), 1997, pp. 100-104
Authors:
KIRAZ S
BALTALI E
GULER N
BARISTA I
BENEKLI M
CELIK I
GULLU IH
KARS A
TEKUZMAN G
FIRAT D
Citation: S. Kiraz et al., IFOSFAMIDE AND ETOPOSIDE IN PREVIOUSLY TREATED PATIENTS WITH ADVANCEDBREAST-CANCER, Tumori, 83(2), 1997, pp. 604-607
Authors:
SAVAS MC
CELIK I
BENEKLI M
KARS A
Citation: Mc. Savas et al., HYALINIZING TRABECULAR ADENOMA OF THYROID MASQUERADING AS THYROID-CARCINOMA, Acta oncologica, 36(4), 1997, pp. 436-437
Authors:
CELIK I
BASCIL N
YALCIN S
GULLU IH
KARS A
BARISTA I
TEKUZMAN G
Citation: I. Celik et al., IFOSFAMIDE-BASED CHEMOTHERAPY FOR RECURRENT OR METASTATIC HEMANGIOPERICYTOMA, Acta oncologica, 36(3), 1997, pp. 348-348
Authors:
KOSTAKOGLU L
UYSAL U
OZYAR E
HAYRAN M
UZAL D
DEMIRKAZIK FB
KARS A
ATAHAN L
BEKDIK CF
Citation: L. Kostakoglu et al., MONITORING RESPONSE TO THERAPY WITH TL-201 AND TECHNETIUM-99M-SESTAMIBI SPECT IN NASOPHARYNGEAL CARCINOMA, The Journal of nuclear medicine, 38(7), 1997, pp. 1009-1014
Authors:
YALCIN S
KARS A
FIRAT P
DEMIRCIN M
TEKUZMAN G
RUACAN S
Citation: S. Yalcin et al., MULTIPLE BILATERAL CHONDROMATOUS HAMARTOMAS OF THE LUNG - A RARE ENTITY MIMICKING METASTATIC CARCINOMA, Respiration, 64(5), 1997, pp. 364-366
Authors:
BENEKLI M
KARS A
GULER N
Citation: M. Benekli et al., MITOXANTRONE-INDUCED BRADYCARDIA, Annals of internal medicine, 126(5), 1997, pp. 409-409
Authors:
KIRAZ S
BALTALI E
GULER N
BARISTA I
BENEKLI M
CELIK I
GULLU IH
KARS A
TEKUZMAN G
FIRAT D
Citation: S. Kiraz et al., IFOSFAMIDE, MESNA AND EPIRUBICIN AS 2ND-LINE CHEMOTHERAPY IN ADVANCEDBREAST-CANCER, Journal of chemotherapy, 8(4), 1996, pp. 310-314
Authors:
GULLU I
YALCIN S
TEKUZMAN G
BARISTA I
ALKIS N
CELIK I
ZENGIN N
GULER N
KARS A
BALTALI E
KANSU E
FIRAT D
Citation: I. Gullu et al., HIGH-DOSE IFOSFAMIDE BY INFUSION WITH MESNA IN ADVANCED REFRACTORY SARCOMAS, Cancer investigation, 14(3), 1996, pp. 239-242
Authors:
CELIK I
KARS A
OZYAR E
TEKUZMAN G
ATAHAN L
FIRAT D
Citation: I. Celik et al., MAJOR TOXICITY OF CISPLATIN, FLUOROURACIL, AND LEUCOVORIN FOLLOWING CHEMORADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA, Journal of clinical oncology, 14(3), 1996, pp. 1043-1044
Authors:
GULLU IH
CELIK I
TEKUZMAN G
ALTUNBAS M
GULER N
BARISTA I
ALKIS N
YALCIN S
KARS A
BALTALI E
KANSU E
FIRAT D
Citation: Ih. Gullu et al., PROCARBAZINE, CCNU, VINCRISTINE COMBINATION IN THE TREATMENT OF BRAIN-TUMORS, Tumori, 82(3), 1996, pp. 228-231
Authors:
BARISTA I
BALTALI E
GULLU IH
GULER N
CELIK I
SARACBASI O
TEKUZMAN G
KARS A
OZISIK Y
RUACAN S
ATAHAN IL
FIRAT D
Citation: I. Barista et al., FACTORS INFLUENCING THE DISTRIBUTION OF METASTASES AND SURVIVAL IN METASTATIC BREAST-CARCINOMA, American journal of clinical oncology, 19(6), 1996, pp. 569-573
Authors:
KOSTAKOGLU L
UYSAL U
OZYAR E
ELAHI N
HAYRAN M
UZAL D
SEMIRKAZIK FB
KARS A
UGUR O
ATAHAN L
BEKDIK CF
Citation: L. Kostakoglu et al., PRE-THERAPY AND POST-THERAPY TL-201 AND TECHNETIUM-99M-SESTAMIBI SPECT IN NASOPHARYNGEAL CARCINOMA, The Journal of nuclear medicine, 37(12), 1996, pp. 1956-1962
Authors:
KARS A
CELIK I
KANSU E
OZISIK Y
GULER N
BARISTA I
GULLU IH
YALCIN S
ALTUNDAG K
ZENGIN N
TEKUZMAN G
BALTALI E
FIRAT D
Citation: A. Kars et al., VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA-2B MAINTENANCE IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3609-3609
Authors:
GULER N
BALTALI E
KARS A
OZISIK Y
ENUNLU T
TEKUZMAN G
OZYILKAN O
ONAT D
GULLU I
BARISTA I
FIRAT D
Citation: N. Guler et al., CMF OR CMF-IIIA BREAST-CARCINOMA(RT AS ADJUVANT THERAPY IN PATIENTS WITH STAGE I), European journal of cancer, 31A, 1995, pp. 70-70